top of page
gradientForSurfBreak.png

Item List

Sep 26, 2023
Strados Labs
Strados Labs Announces Pediatric Asthma Study to Validate its Wearable Device in Children with Wheeze

Strados Labs has partnered with Ann & Robert H. Lurie Children’s Hospital of Chicago for a clinical trial to evaluate the effectiveness of its RESP™ Biosensor in children presenting with wheeze. The RESP™ Biosensor – a novel wearable device used to remotely monitor lung sounds for asthma symptoms such as coughing and wheezing – will be evaluated against a 3M™ Littman digital stethoscope used for episodic auscultation.

Recent Posts

Portfolio Company

Carlsmed.png

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinica ...

Businesswire

Apr 30, 2026

Portfolio Company

Carlsmed.png

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectr ...

BioSpace

Apr 16, 2026

Portfolio Company

Carlsmed.png

The most innovative healthcare companies of 2026 ...

Fast Company

Mar 24, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page